newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) (the "Company" or "NovaBay") today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants,